Works matching IS 00099236 AND DT 2009 AND VI 85

Results: 161

Short-Term Clarithromycin Administration Impairs Clearance and Enhances Pharmacodynamic Effects of Trazodone but Not of Zolpidem.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 644, doi. 10.1038/clpt.2008.293
By:
- Farkas, D.;
- Volak, L. P.;
- Harmatz, J. S.;
- von Moltke, L. L.;
- Court, M. H.;
- Greenblatt, D. J.
Publication type:
Article
Can the Selection and Use of Essential Medicines Decrease Inappropriate Drug Use?
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 581, doi. 10.1038/clpt.2009.10
By:
- Reidenberg, M. M.
Publication type:
Article
Pharmacokinetics of Raltegravir in Individuals With UGT1A1 Polymorphisms.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 623, doi. 10.1038/clpt.2009.12
By:
- Wenning, L. A.;
- Petry, A. S.;
- Kost, J. T.;
- Jin, B.;
- Breidinger, S. A.;
- DeLepeleire, I.;
- Carlini, E. J.;
- Young, S.;
- Rushmore, T.;
- Wagner, F.;
- Lunde, N. M.;
- Bieberdorf, F.;
- Greenberg, H.;
- Stone, J. A.;
- Wagner, J. A.;
- Iwamoto, M.
Publication type:
Article
The Risk of Motor Vehicle Accidents Involving Drivers With Prescriptions for Codeine or Tramadol.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 596, doi. 10.1038/clpt.2009.14
By:
- Bachs, L. C.;
- Engeland, A.;
- Mørland, J. G.;
- Skurtveit, S.
Publication type:
Article
Dose-Dependent Acute and Sustained Renal Effects of the Endothelin Receptor Antagonist Avosentan in Healthy Subjects.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 628, doi. 10.1038/clpt.2009.15
By:
- Smolander, J.;
- Vogt, B.;
- Maillard, M.;
- Zweiacker, C.;
- Littke, T.;
- Hengelage, T.;
- Burnier, M.
Publication type:
Article
Mass Drug Administration and Integrated Control for the World's High-Prevalence Neglected Tropical Diseases.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 659, doi. 10.1038/clpt.2009.16
By:
- Hotez, P. J.
Publication type:
Article
Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 635, doi. 10.1038/clpt.2009.19
By:
- Ho, M. K.;
- Mwenifumbo, J. C.;
- Al Koudsi, N.;
- Okuyemi, K. S.;
- Ahluwalia, J. S.;
- Benowitz, N. L.;
- Tyndale, R. F.
Publication type:
Article
Time-to-Signal Comparison for Drug Safety Data-Mining Algorithms vs. Traditional Signaling Criteria.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 600, doi. 10.1038/clpt.2009.26
By:
- Hochberg, A. M.;
- Hauben, M.
Publication type:
Article
Personalized Dosing of Cyclophosphamide in the Total Body Irradiation–Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 615, doi. 10.1038/clpt.2009.27
By:
- McCune, J. S.;
- Batchelder, A.;
- Guthrie, K. A.;
- Witherspoon, R.;
- Appelbaum, F. R.;
- Phillips, B.;
- Vicini, P.;
- Salinger, D. H.;
- McDonald, G. B.
Publication type:
Article
Health and Economic Consequences of Counterfeit Drugs.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 576, doi. 10.1038/clpt.2009.47
By:
- Seiter, A.
Publication type:
Article
Priority Review Vouchers: An Inefficient and Dangerous Way to Promote Neglected-Disease Drug Development.
Published in:
2009
By:
- Kesselheim, A. S.
Publication type:
Opinion
The Global Portfolio of New Antimalarial Medicines Under Development.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 584, doi. 10.1038/clpt.2009.51
By:
- Olliaro, P.;
- Wells, T. N. C.
Publication type:
Article
Thinking About Broadly Cross-Reactive Vaccines.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 665, doi. 10.1038/clpt.2009.52
By:
- Doherty, P. C.;
- Turner, S. J.
Publication type:
Article
Drug and Vaccine Development for Infectious Diseases: The Value of Priority Review Vouchers.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 571, doi. 10.1038/clpt.2009.53
By:
- Matheny, J.;
- Smith, B.;
- Courtney, B.;
- Mair, M.
Publication type:
Article
Global Challenges for Clinical Pharmacology in the Developing World.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 579, doi. 10.1038/clpt.2009.54
By:
- Blaschke, T. F.
Publication type:
Article
Availability of Medical Countermeasures for Bioterrorism Events: US Legal and Regulatory Options.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 669, doi. 10.1038/clpt.2009.55
By:
- Maher, C.;
- Lushniak, B. D.
Publication type:
Article
In This Issue.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 559, doi. 10.1038/clpt.2009.58
Publication type:
Article
Highlights.
Published in:
2009
Publication type:
Abstract
Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 607, doi. 10.1038/clpt.2009.5
By:
- Hebert, M. F.;
- Ma, X.;
- Naraharisetti, S. B.;
- Krudys, K. M.;
- Umans, J. G.;
- Hankins, G. D. V.;
- Caritis, S. N.;
- Miodovnik, M.;
- Mattison, D. R.;
- Unadkat, J. D.;
- Kelly, E. J.;
- Blough, D.;
- Cobelli, C.;
- Ahmed, M. S.;
- Snodgrass, W. R.;
- Carr, D. B.;
- Easterling, T. R.;
- Vicini, P.
Publication type:
Article
ASCPT News.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 568, doi. 10.1038/clpt.2009.67
Publication type:
Article
World Health and Bioterrorism.
Published in:
2009
By:
- Vincent, J.
Publication type:
Editorial
Factors Associated With Exacerbation of Heart Failure Include Treatment Adherence and Health Literacy Skills.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 6, p. 651, doi. 10.1038/clpt.2009.7
By:
- Murray, M. D.;
- Tu, W.;
- Wu, J.;
- Morrow, D.;
- Smith, F.;
- Brater, D. C.
Publication type:
Article
Assessment of MAO-B Occupancy in the Brain With PET and [<sup>11</sup>C]-L-Deprenyl-D<sub>2</sub>: A Dose-Finding Study With a Novel MAO-B Inhibitor, EVT 301.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 506, doi. 10.1038/clpt.2008.241
By:
- Hirvonen, J.;
- Kailajärvi, M.;
- Haltia, T.;
- Koskimies, S.;
- Någren, K.;
- Virsu, P.;
- Oikonen, V.;
- Sipilä, H.;
- Ruokoniemi, P.;
- Virtanen, K.;
- Scheinin, M.;
- Rinne, J. O.
Publication type:
Article
Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 513, doi. 10.1038/clpt.2008.250
By:
- Komoroski, B.;
- Vachharajani, N.;
- Feng, Y.;
- Li, L.;
- Kornhauser, D.;
- Pfister, M.
Publication type:
Article
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 520, doi. 10.1038/clpt.2008.251
By:
- Komoroski, B.;
- Vachharajani, N.;
- Boulton, D.;
- Kornhauser, D.;
- Geraldes, M.;
- Li, L.;
- Pfister, M.
Publication type:
Article
Pro32Thr Polymorphism of Inosine Triphosphate Pyrophosphatase Gene Predicts Efficacy of Low-Dose Azathioprine for Patients With Systemic Lupus Erythematosus.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 527, doi. 10.1038/clpt.2008.261
By:
- Okada, Y.;
- Nakamura, K.;
- Hiromura, K.;
- Nojima, Y.;
- Horiuchi, R.;
- Yamamoto, K.
Publication type:
Article
Heart Rhythm Disturbances Associated With Rupatadine: A Case Series From the Spanish and Portuguese Pharmacovigilance Systems.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 481, doi. 10.1038/clpt.2008.269
By:
- Carvajal, A.;
- Macías, D.;
- Salado, I.;
- Sáinz, M.;
- Ortega, S.;
- Campo, C;
- García del Pozo, J.;
- Martín Arias, L. H.;
- Velasco, A.;
- Gonçalves, S.;
- Pombal, R.;
- Carmona, R.
Publication type:
Article
Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 485, doi. 10.1038/clpt.2008.271
By:
- Arab-Alameddine, M.;
- Di Iulio, J.;
- Buclin, T.;
- Rotger, M.;
- Lubomirov, R.;
- Cavassini, M.;
- Fayet, A.;
- Décosterd, L. A.;
- Eap, C. B.;
- Biollaz, J.;
- Telenti, A.;
- Csajka, C.
Publication type:
Article
Nanomedicine and Society.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 466, doi. 10.1038/clpt.2008.276
By:
- Ferrari, M.;
- Philibert, M. A.;
- Sanhai, W. R.
Publication type:
Article
The Effect of Activated Charcoal on Drug Exposure in Healthy Volunteers: A Meta-Analysis.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 501, doi. 10.1038/clpt.2008.278
By:
- Jürgens, G.;
- Groth Hoegberg, L. C.;
- Graudal, N. A.
Publication type:
Article
Delivery of Biologics in Cardiovascular Regenerative Medicine.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 548, doi. 10.1038/clpt.2008.295
By:
- Bartunek, J.;
- Sherman, W.;
- Vanderheyden, M.;
- Fernandez-Aviles, F.;
- Wijns, W.;
- Terzic, A.
Publication type:
Article
Small Solutions for Big Problems: The Application of Nanoparticles to Brain Tumor Diagnosis and Therapy.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 531, doi. 10.1038/clpt.2008.296
By:
- Orringer, D. A.;
- Koo, Y. E.;
- Chen, T.;
- Kopelman, R.;
- Sagher, O.;
- Philbert, M. A.
Publication type:
Article
Ophthalmic Drug Delivery: Development and Regulatory Considerations.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 539, doi. 10.1038/clpt.2008.297
By:
- Novack, G. D.
Publication type:
Article
Inappropriate Medications and Adverse Drug Reactions in the Elderly.
Published in:
2009
By:
- Gallagher, P.;
- O'Mahony, D.
Publication type:
Letter
Studies Should Be Controlled, Randomized, and Blinded.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 461, doi. 10.1038/clpt.2009.13
By:
- Parker, R. A.
Publication type:
Article
Response to “Inappropriate Medications and Adverse Drug Reactions in the Elderly”.
Published in:
2009
By:
- Laroche, M.-L.;
- Charmes, J.-P.;
- Bouthier, F.;
- Merle, L.
Publication type:
Letter
CORRIGENDUM: PI-34: An Analysis of Subjects in Clinical Trials Who, After Dosing, Report Predose Adverse Events and Abnormalities in Their Medical Histories.
Published in:
2009
Publication type:
Correction Notice
Combination Products Regulation at the FDA.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 468, doi. 10.1038/clpt.2009.28
By:
- Lauritsen, K. J.;
- Nguyen, T.
Publication type:
Article
Methods for Female Contraception: A Model for Innovation in Drug Delivery Systems.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 553, doi. 10.1038/clpt.2009.29
By:
- Merkatz, R. B.;
- Tokay, B.;
- Sitruk-Ware, R. L.
Publication type:
Article
Drug Delivery in the Twenty-First Century: A New Paradigm.
Published in:
2009
By:
- Smith, B.;
- Uhl, K.
Publication type:
Editorial
How Well Does Blinding Work in Randomized Controlled Trials?: A Counterpoint.
Published in:
2009
By:
- Boehmer, J.;
- Yong, P.
Publication type:
Opinion
In This Issue.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 449, doi. 10.1038/clpt.2009.36
Publication type:
Article
Highlights.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 456, doi. 10.1038/clpt.2009.37
Publication type:
Article
ASCPT News.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 458, doi. 10.1038/clpt.2009.38
Publication type:
Article
UGT Genotype May Contribute to Adverse Events Following Medication With Mycophenolate Mofetil in Pediatric Kidney Transplant Recipients.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 495, doi. 10.1038/clpt.2009.3
By:
- Prausa, S. E.;
- Fukuda, T.;
- Maseck, D.;
- Curtsinger, K. L.;
- Liu, C.;
- Zhang, K.;
- Nick, T. G.;
- Sherbotie, J. R.;
- Ellis, E. N.;
- Goebel, J.;
- Vinks, A. A.
Publication type:
Article
CORRIGENDUM: Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus.
Published in:
2009
Publication type:
Correction Notice
The Next Generation of Drug-Delivery Microdevices.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 544, doi. 10.1038/clpt.2009.4
By:
- Elman, N. M.;
- Patta, Y.;
- Scott, A. W.;
- Masi, B.;
- Ho Duc, H. L.;
- Cima, M. J.
Publication type:
Article
A Critical Appraisal of the Safety and Efficacy of Drug-Eluting Stents.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 474, doi. 10.1038/clpt.2009.8
By:
- Maluenda, G.;
- Lemesle, G.;
- Waksman, R.
Publication type:
Article
Predictive Biomarkers in the Development of Oncology Drugs: A Therapeutic Industry Perspective.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 535, doi. 10.1038/clpt.2009.9
By:
- Fine, B. M.;
- Amler, L.
Publication type:
Article
The Dutch Vision of Clinical Pharmacology.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 4, p. 366, doi. 10.1038/clpt.2008.148
By:
- Schellens, J. H. M.;
- Grouls, R.;
- Guchelaar, H. J.;
- Touw, D. J.;
- Rongen, G. A.;
- de Boer, A.;
- Van Bortel, L. M.
Publication type:
Article